519 results on '"Moline, Margaret"'
Search Results
102. Circadian Rhythms and Photoperiodism
103. Lack of residual morning effects of lemborexant treatment for insomnia: summary of findings across 9 clinical trials
104. Efficacy and Safety of Lemborexant Across 12 Months in Elderly Subjects With Insomnia Disorder
105. Efficacy and Safety of Lemborexant in Subjects Previously Randomized to Placebo for 6 Months
106. Population Pharmacokinetics and Exposure‐Response Analyses for the Most Frequent Adverse Events Following Treatment With Lemborexant, an Orexin Receptor Antagonist, in Subjects With Insomnia Disorder
107. Long-term efficacy and tolerability of lemborexant compared with placebo in adults with insomnia disorder: results from the phase 3 randomized clinical trial SUNRISE 2
108. Pharmacokinetics, Pharmacodynamics, and Safety of the Dual Orexin Receptor Antagonist Lemborexant: Findings From Single‐Dose and Multiple‐Ascending‐Dose Phase 1 Studies in Healthy Adults
109. Safety of lemborexant versus placebo and zolpidem: effects on auditory awakening threshold, postural stability, and cognitive performance in healthy older participants in the middle of the night and upon morning awakening
110. Erratum to: On-the-road driving performance the morning after bedtime administration of lemborexant in healthy adult and elderly volunteers
111. Efficacy and Safety of Lemborexant vs Zolpidem Extended Release and Placebo in Elderly Subjects with Insomnia: Results from SUNRISE-1 (1868)
112. Impact of Lemborexant Treatment on Insomnia Disease Severity and Fatigue: Results from the 12-Month Phase 3 Study SUNRISE-2 (112)
113. Effectiveness and Safety of Lemborexant Over 12 Months in Adults with Insomnia Disorder: Longterm Results From the Phase 3 SUNRISE-2 Study (420)
114. SUBJECT-REPORTED PERCEPTION OF LONG-TERM EFFECTIVENESS OF LEMBOREXANT VERSUS PLACEBO IN NONELDERLY AND ELDERLY SUBGROUPS
115. 164 Pooled Analyses of Patient-Reported Sleep Onset and Maintenance from Two Phase 3 Studies of Lemborexant
116. IMPACT OF LEMBOREXANT ON INSOMNIA DISEASE SEVERITY AND FATIGUE IN ELDERLY SUBJECTS WITH INSOMNIA FROM SUNRISE-2
117. 165 Impact of Lemborexant on Insomnia Disease Severity and Fatigue: Results from the 6-Month Placebo-Controlled Period of the Phase 3 SUNRISE-2 Study
118. Respiratory safety of lemborexant in healthy adult and elderly subjects with mild obstructive sleep apnea: A randomized, double‐blind, placebo‐controlled, crossover study
119. Comparison of Lemborexant With Placebo and Zolpidem Tartrate Extended Release for the Treatment of Older Adults With Insomnia Disorder
120. Randomized, Placebo-Controlled, Clinical Trial of Donepezil in Vascular Dementia: Differential Effects by Hippocampal Size
121. Premenstrual Syndrome: Identification and Management
122. Sleep in women across the life cycle from adulthood through menopause
123. Pediatricians and sleep disorders: training and practice
124. 0388 Lemborexant Effect on Sleep Parameters in Adults with Moderate or Severe Chronic Obstructive Pulmonary Disease
125. Treatment of Depression in Women: A Summary of the Expert Consensus Guidelines
126. Sleep in women across the life cycle from adulthood through menopause
127. Long-term safety and tolerability of donepezil 23 mg in patients with moderate to severe Alzheimer’s disease
128. F1‐06‐04: RESPONSE TO TREATMENT WITH LEMBOREXANT: SUBJECTS WITH IRREGULAR SLEEP‐WAKE RHYTHM DISORDER AND ALZHEIMER'S DISEASE DEMENTIA
129. Effects of Lemborexant in the Morning: Results From 3 Randomized Studies (S46.007)
130. 0371 Lemborexant Treatment for Insomnia in Phase 3: Impact on Disease Severity
131. 0368 Efficacy and Tolerability of Lemborexant in Female and Male Subjects with Insomnia
132. 0367 Lemborexant Treatment for Insomnia: 6-month Safety
133. 0429 Respiratory Safety of Lemborexant in Adult and Elderly Subjects with Mild Obstructive Sleep Apnea
134. 0370 Patient-reported Sleep Onset and Sleep Maintenance: Pooled Analyses of Lemborexant Phase 3 Studies
135. 0369 Effect of Lemborexant on Sleep Architecture in Older Adults with Insomnia Disorder
136. 0430 Respiratory Safety of Lemborexant in Healthy Adult and Elderly Subjects
137. 0056 SAMP8 Mice As A Preclinical Model For Irregular Sleep Wake Rhythm Disorder And Efficacy Of The Dual Orexin (Hypocretin) Receptor Antagonist Lemborexant
138. EFFICACY OF LEMBOREXANT COMPARED WITH ZOLPIDEM EXTENDED RELEASE AND PLACEBO IN ELDERLY SUBJECTS WITH INSOMNIA: RESULTS FROM A PHASE 3 STUDY (SUNRISE 1)
139. SAFETY OF LEMBOREXANT IN ELDERLY SUBJECTS WITH INSOMNIA: RESULTS FROM A PHASE 3 STUDY (SUNRISE 1)
140. Safety and tolerability of donepezil 23 mg in moderate to severe Alzheimer's disease
141. On-the-road driving performance the morning after bedtime administration of lemborexant in healthy adult and elderly volunteers
142. Hormone Replacement Therapy and Late-Life Mania
143. Pharmacokinetics, Pharmacodynamics, and Safety of the Dual Orexin Receptor Antagonist Lemborexant: Findings From Single‐Dose and Multiple‐Ascending‐Dose Phase 1 Studies in Healthy Adults.
144. Lack of residual morning effects of lemborexant treatment for insomnia: summary of findings across 9 clinical trials.
145. High nocturnal body temperature in premenstrual syndrome and late luteal phase dysphoric disorder
146. Safety and Efficacy of Lemborexant in Patients With Irregular Sleep-Wake Rhythm Disorder and Alzheimer's Disease Dementia: Results From a Phase 2 Randomized Clinical Trial.
147. P3‐015: CIRCADIAN RHYTHM CHARACTERISTICS MEASURED WITH ACTIGRAPHY IN PATIENTS WITH IRREGULAR SLEEP‐WAKE RHYTHM DISORDER AND ALZHEIMER'S DISEASE
148. Lemborexant, A Dual Orexin Receptor Antagonist (DORA) for the Treatment of Insomnia Disorder: Results From a Bayesian, Adaptive, Randomized, Double-Blind, Placebo-Controlled Study
149. RESPONSE TO TREATMENT WITH LEMBOREXANT: SUBJECTS WITH IRREGULAR SLEEP-WAKE RHYTHM DISORDER AND ALZHEIMER’S DISEASE DEMENTIA
150. Commentary on Yue et al. Efficacy and tolerability of pharmacological treatments for insomnia in adults: A systematic review and network meta-analysis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.